Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Invested Capital (2020 - 2025)

Core Scientific's Invested Capital history spans 6 years, with the latest figure at $844000.0 for Q4 2025.

  • For Q4 2025, Invested Capital rose 100.1% year-over-year to $844000.0; the TTM value through Sep 2025 reached -$1.1 billion, down 36.84%, while the annual FY2025 figure was $844000.0, 100.1% up from the prior year.
  • Invested Capital for Q4 2025 was $844000.0 at Core Scientific, up from -$1.1 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $1.3 billion in Q4 2021 and bottomed at -$1.2 billion in Q2 2025.
  • The 5-year median for Invested Capital is -$340.7 million (2023), against an average of -$237.4 million.
  • The largest annual shift saw Invested Capital soared 1403.19% in 2021 before it crashed 563.5% in 2023.
  • A 5-year view of Invested Capital shows it stood at $1.3 billion in 2021, then plummeted by 130.52% to -$409.3 million in 2022, then crashed by 45.83% to -$596.9 million in 2023, then tumbled by 37.12% to -$818.5 million in 2024, then surged by 100.1% to $844000.0 in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Invested Capital are $844000.0 (Q4 2025), -$1.1 billion (Q3 2025), and -$1.2 billion (Q2 2025).